Evidera
Katherine Kirk, MPH, currently serves as a Research Associate III at Evidera since January 2022, having begun as a Research Associate II. Prior to this role, Katherine worked as a Research Associate II at Clinical Outcomes Solutions from June 2019 to December 2021, gaining extensive experience in desk research, qualitative coding using NVivo software, and patient interviews, while also collaborating with the marketing team to develop company newsletters. Katherine's earlier experience includes working as a Research Intern at Archer Family Medical Group, LLC, where collaboration with the lead physician focused on research design to educate the community about Human papillomavirus (HPV) and the GARDASIL®9 vaccination. Katherine holds a Master of Public Health (MPH) from Benedictine University, where various certificates in Health Management and Policy and Epidemiology were also obtained, along with a Bachelor of Science (B.S.) in Health Science.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.